1-9 of 9
naproxen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Drug Metabolites Formed in Vivo Promote the Clearance of Human Platelets by Metabolite-Dependent Antibodies in NOD/SCID Mice

Daniel W. Bougie, PhD, Dhirendra Nayak, Richard H. Aster, MD
Journal: Blood
Blood (2012) 120 (21): 1083.
https://doi.org/10.1182/blood.V120.21.1083.1083
Published: 2012
Journal Articles

Identifying Drugs Implicated in Drug-Induced Immune Thrombocytopenia Using Levels of Evidence Applied to Laboratory Tests,

Donald M. Arnold, MD, Theodore E. Warkentin, MD, James W. Smith, BSc, Aliya Esmail, Sadiya Kukaswadia, MD, Lori Dewar, John G. Kelton, MD, FRCPC
Journal: Blood
Blood (2011) 118 (21): 3304.
https://doi.org/10.1182/blood.V118.21.3304.3304
Published: 2011
Journal Articles

Co-Administration of YM150, An Oral Direct Factor Xa Inhibitor, and Naproxen Does Not Result In Clinically Relevant Changes to the Pharmacodynamic or Pharmacokinetic Profile of Either Agent

Marten Heeringa, Alberto Garcia-Hernandez, Takeshi Kadokura, Dorien Groenendaal – van de Meent, Gregory Strabach, Roelof Mol, Charlotte Eltink, Hartmut Heinzerling
Journal: Blood
Blood (2010) 116 (21): 4393.
https://doi.org/10.1182/blood.V116.21.4393.4393
Published: 2010
Journal Articles

Drug Metabolites Produced In Vivo Promote Clearance of Human Platelets by Metabolite-Specific Antibodies in NOD/Scid Mice.

Daniel W. Bougie, PhD, Dhirendra Nayak, Richard H. Aster, MD
Journal: Blood
Blood (2009) 114 (22): 2408.
https://doi.org/10.1182/blood.V114.22.2408.2408
Published: 2009
Journal Articles

Naproxen Has No Relevant Effect on the Safety, Tolerability, Pharmacodynamics, and Pharmacokinetics of BAY 59-7939 - An Oral, Direct Factor Xa Inhibitor.

Dagmar Kubitza, MD, PhD, Michael Becka, MD, Wolfgang Mueck, MD, Michael Zuehlsdorf, MD
Journal: Blood
Blood (2005) 106 (11): 1873.
https://doi.org/10.1182/blood.V106.11.1873.1873
Published: 2005
Journal Articles

Effects of Non-Steroidal Anti-Inflammatory Drugs and COX-2 Inhibitors on Aspirin-Induced Platelet Inhibition.

Carol Sun, B.S., Angela Bergeron, B.S., Jennifer Wood, Ph.D., Jo Ellen Schweinle, M.D., Frank L. Lanza, M.D., Byron Cryer, M.D., Jin-Fei Dong, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 531.
https://doi.org/10.1182/blood.V104.11.531.531
Published: 2004
Journal Articles

Effects of Combining Aspirin with Non-Steroidal Anti-Inflammatory Drugs or COX-2 Inhibitors on Shear-Induced Platelet Aggregation.

Angela Bergeron, B.S., Carol Sun, B.S., Jennifer Wood, Ph.D., Jo Ellen Schweinle, M.D., Frank L. Lanza, M.D., Byron Cryer, M.D., Jing-Fei Dong, M.D., Ph.D.
Journal: Blood
Blood (2004) 104 (11): 1853.
https://doi.org/10.1182/blood.V104.11.1853.1853
Published: 2004
Journal Articles

Acute Hyperglycaemia Enhances Platelet Activation: Involvement of Multiple Mechanisms.

Nailin Li, MD, PhD, Dzana Sudic, BS, Mikael Forslund, MD, Masoud Razmara, BS
Journal: Blood
Blood (2004) 104 (11): 3884.
https://doi.org/10.1182/blood.V104.11.3884.3884
Published: 2004
Journal Articles

Immune thrombocytopenia resulting from sensitivity to metabolites of naproxen and acetaminophen

Daniel Bougie, Richard Aster
Journal: Blood
Blood (2001) 97 (12): 3846–3850.
https://doi.org/10.1182/blood.V97.12.3846
Published: 2001